EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Triple Laser Combination Treatment for Facial Angiofibromata Management in Tuberous Sclerosis and Literature Review

F Neamonitou iD, K K Neamonitos iD, S Stavrianos iD, K P Neamonitos iD

Archives of Plastic Surgery · 01.07.2024 · 51 (04) · 372-377

DOI: 10.1055/a-2306-0962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Plastic Surgery, erschienen am 01.07.2024. Verfasst von F Neamonitou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, General Anticancer Oncological Hospital of Athens 'Saint Savvas', Athens, Greece. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiofibromas are a common facial manifestation of tuberous sclerosis (TS). However, current treatments have proven ineffective due to high recurrence rates and noncompliance. To address this issue, we developed a new triple laser therapy protocol for more effective management of angiofibromas. We conducted tests to validate its efficacy. This is a prospective study of 10 patients with TS (4 women and 6 men, mean age 26.3 years [15–37 years]) with angiofibromata who received triple sequential laser therapy at our private dermatological clinic conducted from January 2000 to December 2022. We evaluated the outcome with the Facial Angiofibromata Severity Index (FASI) via clinical photography (0, 6 months, 1 year, and 2 years), and Dermatology Life Quality Index (DLQI). All patients had a successful recovery without any complications. Among these 10 patients, 4 experienced localized recurrences at their 6-month follow-up. These recurrences were treated with a second single carbon dioxide laser session. After 2 years of follow-up, we observed no recurring facial cutaneous manifestations. Furthermore, all patients experienced a decrease in their FASI score after treatment. According to the Visual Analogue Scale, patients reported 95% satisfaction, and DLQI indicated only a minor impact on their everyday lives. We believe that this protocol of three-step laser treatment is effective, safe, and compliable for patients with facial angiofibromata, providing a satisfactory outcome adaptable to the daily dermatological and plastic surgery practice.

Schlagwörter

Stichwörter der Autor:innen

Erbiumangiofibromalaserpulsed dye lasertuberous sclerosis

Autor:innen und Institutionen

  • Department of Plastic Surgery, General Anticancer Oncological Hospital of Athens 'Saint Savvas', Athens, Greece.
  • Department of Dermatology, General University Hospital of Athens 'Attikon', Athens, Greece.
  • Hellenic Society of Dermatology Surgery (HSDS), Private Dermatological Clinic 'Laserderm Academy', Athens, Greece.

ORCID-Profile: F Neamonitou, K K Neamonitos, S Stavrianos, K P Neamonitos

Zitieren

APA

Neamonitou, F., Neamonitos, K. K., Stavrianos, S., & Neamonitos, K. P. (2024). A Triple Laser Combination Treatment for Facial Angiofibromata Management in Tuberous Sclerosis and Literature Review. Archives of Plastic Surgery, 51(04), 372-377. https://doi.org/10.1055/a-2306-0962

Vancouver

Neamonitou F, Neamonitos KK, Stavrianos S, Neamonitos KP. A Triple Laser Combination Treatment for Facial Angiofibromata Management in Tuberous Sclerosis and Literature Review. Archives of Plastic Surgery. 2024;51(04):372-377. doi:10.1055/a-2306-0962

BibTeX
@article{Neamonitou2024,
  author = {Neamonitou, F and Neamonitos, K K and Stavrianos, S and Neamonitos, K P},
  title = {A Triple Laser Combination Treatment for Facial Angiofibromata Management in Tuberous Sclerosis and Literature Review},
  journal = {Archives of Plastic Surgery},
  year = {2024},
  volume = {51},
  number = {04},
  pages = {372--377},
  doi = {10.1055/a-2306-0962}
}
Kostenlos starten →